Changes to Medication Naming in Australia

The Therapeutic Goods Administration (TGA) has announced that Australia will be implementing changes to medication names by 2020, to align with the international standardised medication names.

Changes to Medication Naming in Australia

The Therapeutic Goods Administration (TGA) has announced that Australia will be implementing changes to medication names by 2020, to align with the international standardised medication names. This move away from the Australian Approved Names (AAN) is to be in alignment with the International Non-proprietary Names (INNs), which has been developed by the World Health Organisation (WHO). This change will lead to long term benefits with medication safety, as patients and healthcare professionals who travel internationally will experience less confusion. It will also allow the simplification of searching for a particular medication such as the use of frusemide in acute pulmonary oedema, and not capturing a study that uses the name furosemide, or studies that involve epinephrine rather than adrenaline in the title or keywords. Both the UK and New Zealand underwent the same process in 2003 and 2008 respectively.

Some medications that have been deemed high risk will include both names on the label, as the potential for errors during emergency situations is high. Some examples of medication used in Advanced Life Support (ALS) and Paediatric Advanced Life Support (PALS) include: adrenaline (epinephrine), noradrenaline (norepinephrine), and lidocaine (lignocaine). Healthcare professionals with ALS and PALS certification should be aware of these changes, to reduce confusion and errors during critical events. A full list of the TGA changes can be found at https://www.tga.gov.au/updating-medicine-ingredient-names-list-affected-ingredients.

If you are looking to update your certification in ALS and PALS, please see our upcoming events in Melbourne and Sydney below.
3rd & 4th August: Melbourne (ALS and PALS)
11 & 12th October: Sydney (ALS)
13th October: Sydney (PALS)
25th & 26th October: Melbourne (ALS)
27th October: Melbourne (PALS)

References:
NPS Medicinewise, Department of Health, Australian Government, published 1 June 2017, https://www.nps.org.au/australian-prescriber/articles/changing-australian-medicine-names

Therapeutic Goods Administration, Department of Health, Australian Government, published 23 April 2019, https://www.tga.gov.au/labelling-changes-information-health-professionals

{{commentCount}} comment(s). You must be logged in and AHPRA verified to view and comment. Login here.
Ken Hambrecht

Ken Hambrecht

Ken is the Founder and Principal Consultant for Critical Care Education Services (part of the Medcast Group).
Ph: 1300 898 973 www.criticalcare.edu.au

The latest healthcare news from medcast

Vaping - Friend or Foe?
Vaping - Friend or Foe?

Where are we with vaping? Are e-cigarettes the shining knight who will rid the world of cigarettes or dangerous products wrapped up in clever marketing with the 'unintended consequence' of luring young people into the world of smoking?

On being a GP seeking help
On being a GP seeking help

I had an interesting experience at my GP recently. I don’t go to the GP very often. Mostly I don’t get sick. Sometimes I treat my own ills or just soldier on. On the few occasions that I have been to see someone about something concerning me, my overwhelming experience has been of being judged and dismissed. I feel that they think that, as a doctor, I should have not only made the diagnosis but also treated myself. In fact, I should have been better way before I thought to come along!

Let’s talk about self-soothing
Let’s talk about self-soothing

I talk to a lot of health professionals and it amazes me how often people look at me blankly when I introduce the subject of self-soothing activities. As the conversation progresses I can see most of the blank looks turn to some degree of understanding as they begin to acknowledge the familiarity of the concept in their own lives, but GPs in particular are not generally familiar with the fact that teaching people about emotional management strategies is a core part of therapy, and an intervention that is entirely available to them in general practice.

Can I have medical cannabis on PBS doctor?
Can I have medical cannabis on PBS doctor?

I’ve been asked this question twice in the last month. Once by a 70 year old patient who has taken up smoking weed to control her neuropathic pain, let’s call her ‘Rachel’. And the other a young man aged 26 (Sean) who is smoking cannabis to help control his chronic anxiety.

Join Medcast. It's free and you'll get instant access to essential healthcare news, research and more.

Already a member? Sign-in